Literature DB >> 16989257

Fedbatch culture and dynamic nutrient feeding.

Katie F Wlaschin1, Wei-Shou Hu.   

Abstract

In the past decade, we have seen a rapid expansion in mammalian cell based therapeutic proteins reaching clinical applications. This increased demand has been met with much increased productivity through intensive process development. During this time, fedbatch culture processes have emerged as the predominant mode for producing recombinant proteins. In this review, we discuss the fundamentals of fedbatch culture process design, focusing on the use of stoichiometric nutrient requirements for feed medium formulation, and articulating the need and potential means for devising rational dynamic feeding schemes. Incorporation of on-line nutrient measurement will play a key role in further refinement of process control for the development of a much sought after generic feeding strategy that can respond to the changing demands of different cell lines in a fluctuating culture environment. The future of process engineering will likely require a combination of current process engineering strategies along with a better understanding and control over cell physiology. Process development will likely to entail not only optimizing traditional engineering parameters but also engineering cell lines with desired characteristics. The integration of cell engineering and process intensification will likely provide the stimuli that propel the limits of growth and productivity to the next high level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989257     DOI: 10.1007/10_015

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  9 in total

1.  Comparison of viable cell concentration estimation methods for a mammalian cell cultivation process.

Authors:  M Aehle; R Simutis; A Lübbert
Journal:  Cytotechnology       Date:  2010-09-01       Impact factor: 2.058

2.  A test facility for fritted spargers of production-scale-bioreactors.

Authors:  C Sieblist; M Aehle; M Pohlscheidt; M Jenzsch; A Lübbert
Journal:  Cytotechnology       Date:  2010-12-15       Impact factor: 2.058

3.  Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.

Authors:  Huifeng Zhang; Haibin Wang; Mei Liu; Tao Zhang; Ji Zhang; Xiangjing Wang; Wensheng Xiang
Journal:  Cytotechnology       Date:  2012-08-21       Impact factor: 2.058

Review 4.  Metabolic flux rewiring in mammalian cell cultures.

Authors:  Jamey D Young
Journal:  Curr Opin Biotechnol       Date:  2013-05-28       Impact factor: 9.740

5.  Back to the future: recombinant polyclonal antibody therapeutics.

Authors:  Xian-Zhe Wang; Vincent W Coljee; Jennifer A Maynard
Journal:  Curr Opin Chem Eng       Date:  2013-11       Impact factor: 5.163

6.  Efficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression system.

Authors:  Qinzhen Cai; Ai Zhao; Lisha Ma; Zhenzhen Jiao; Huilin Zhi; Shouhua Lai; Sha Cheng; Hongmei Yang; Yinxiang Lu; Katherine A Siminovitch; Jimin Gao
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

7.  Metabolic Control in Mammalian Fed-Batch Cell Cultures for Reduced Lactic Acid Accumulation and Improved Process Robustness.

Authors:  Viktor Konakovsky; Christoph Clemens; Markus Michael Müller; Jan Bechmann; Martina Berger; Stefan Schlatter; Christoph Herwig
Journal:  Bioengineering (Basel)       Date:  2016-01-11

8.  A Simple Method to Reduce both Lactic Acid and Ammonium Production in Industrial Animal Cell Culture.

Authors:  Nathaniel W Freund; Matthew S Croughan
Journal:  Int J Mol Sci       Date:  2018-01-28       Impact factor: 5.923

9.  Over-expression of a Codon Optimized Yeast Cytosolic Pyruvate Carboxylase (PYC2) in CHO Cells for an Augmented Lactate Metabolism.

Authors:  Sanjeev K Gupta; Ankit Sharma; Hiralal Kushwaha; Pratyoosh Shukla
Journal:  Front Pharmacol       Date:  2017-07-17       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.